A dynamic interplay between alternative polyadenylation and microRNA regulation: Implications for cancer (Review)

International Journal of Oncology

Volumn 43, Issue 4, 2013, Pages 995-1001

  An, Jindan ^a,b   Zhu, Xiaodong ^a   Wang, Hongwei ^b   Jin, Xiudong ^a  

^a Key Laboratory of Cancer Prevention and Treatment of Heilongjiang Province   (United States)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Alternative polyadenylation; Cancer; MicroRNA; Proliferation

Indexed keywords

CYCLIN D1; CYCLOOXYGENASE 2; MICRORNA; RNA ISOFORM;

3' UNTRANSLATED REGION; ARTICLE; CELL PROLIFERATION; GENE CONTROL; HUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; START CODON; STOP CODON;

3' UNTRANSLATED REGIONS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEOPLASMS; POLYADENYLATION; RNA, MESSENGER;

EID: 84882442706     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2047     Document Type: Article

References (81)

1. Venter JC, Adams MD, Myers EW, et al: The sequence of the human genome. Science 291: 1304-1351, 2001.
2. Lander ES, Linton LM, Birren B, et al: Initial sequencing and analysis of the human genome. Nature 409: 860-921, 2001.
3. Mignone F, Gissi C, Liuni S and Pesole G: Untranslated regions of mRNAs. Genome Biol 3: Reviews 0004, 2002.
4. Maniatis T and Reed R: An extensive network of coupling among gene expression machines. Nature 416: 499-506, 2002.
5. Lackner DH, Beilharz TH, Marguerat S, et al: A network of multiple regulatory layers shapes gene expression in fission yeast. Mol Cell 26: 145-155, 2007.
6. de la Grange P, Dutertre M, Correa M and Auboeuf D: A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants. BMC Bioinformatics 8: 180, 2007.
7. Wang ET, Sandberg R, Luo S, et al: Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476 2008.
8. Tian B, Pan Z and Lee JY: Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing. Genome Res 17: 156-165, 2007.
9. Hon LS and Zhang Z: The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression. Genome Biol 8: R166, 2007.
10. Farh KK, Grimson A, Jan C, et al: The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817-1821, 2005.
11. Ro S, Park C, Young D, Sanders KM and Yan W: Tissue-dependent paired expression of miRNAs. Nucleic Acids Res 35: 5944-5953, 2007.
12. Rodriguez A, Griffiths-Jones S, Ashurst JL and Bradley A: Identification of mammalian microRNA host genes and transcription units. Genome Res 14: 1902-1910, 2004.
13. Linsley PS, Schelter J, Burchard J, et al: Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 27: 2240-2252, 2007.
14. Kertesz S, Kerenyi Z, Merai Z, et al: Both introns and long 3'-UTRs operate as cis-acting elements to trigger nonsense-mediated decay in plants. Nucleic Acids Res 34: 6147-6157, 2006.
15. Gilat R and Shweiki D: A novel function for alternative polyadenylation as a rescue pathway from NMD surveillance. Biochem Biophys Res Commun 353: 487-492, 2007.
16. Lewis BP, Green RE and Brenner SE: Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 100: 189-192, 2003.
17. Makeyev EV, Zhang J, Carrasco MA and Maniatis T: The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27: 435-448, 2007.
18. Durand C, Roeth R, Dweep H, et al: Alternative splicing and nonsense-mediated RNA decay contribute to the regulation of SHOX expression. PloS ne 6: e18115, 2011.
19. Li XL, Andersen JB, Ezelle HJ, Wilson GM and Hassel BA: Post-transcriptional regulation of RNase-L expression is mediated by the 3'-untranslated region of its mRNA. J Biol Chem 282: 7950-7960, 2007.
20. Rimokh R, Berger F, Bastard C, et al: Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood 83: 3689-3696, 1994.
21. von Roretz C and Gallouzi IE: Decoding ARE-mediated decay: is microRNA part of the equation? J Cell Biol 181: 189-194, 2008.
22. Muhlrad D and Parker R: Aberrant mRNAs with extended 3' UTRs are substrates for rapid degradation by mRNA surveillance. RNA 5: 1299-1307, 1999.
23. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
24. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
25. Friedman RC, Farh KK, Burge CB and Bartel D: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2008.
26. Yekta S, Shih IH and Bartel DP: MicroRNA-directed cleavage of HOXB8 mRNA. Science 304: 594-596, 2004.
27. Pillai RS, Bhattacharyya SN, Artus CG, et al: Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309: 1573-1576, 2005.
28. Wu L, Fan J and Belasco JG: MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA 103: 4034-4039, 2006.
29. Didiano D and Hobert O: Molecular architecture of a miRNA-regulated 3' UTR. RNA 14: 1297-1317, 2008.
30. Stark A, Brennecke J, Bushati N, Russell RB and Cohen SM: Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123: 1133-1146, 2005.
31. Kertesz M, Iovino N, Unnerstall U, Gaul U and Segal E: The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284, 2007.
32. Lopez F, Granjeaud S, Ara T, Ghattas B and Gautheret D: The disparate nature of 'intergenic' polyadenylation sites. RNA 12: 1794-1801, 2006.
33. Legendre M and Gautheret D: Sequence determinants in human polyadenylation site selection. BMC Genomics 4: 7, 2003.
34. Kubo T, Wada T, Yamaguchi Y, Shimizu A and Handa H: Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs. Nucleic Acids Res 34: 6264-6271, 2006.
35. Edwalds-Gilbert G, Veraldi KL and Milcarek C: Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res 25: 2547-2561, 1997.
36. Ara T, Lopez F, Ritchie W, Benech P and Gautheret D: Conservation of alternative polyadenylation patterns in mammalian genes. BMC Genomics 7: 189, 2006.
37. Zhang H, Lee JY and Tian B: Biased alternative polyadenylation in human tissues. Genome Biol 6: R100, 2005.
38. Feng Z, Wu CF, Zhou X and Kuang J: Alternative polyadenylation produces two major transcripts of Alix. Arch Biochem Biophys 465: 328-335, 2007.
39. Moucadel V, Lopez F, Ara T, Benech P and Gautheret D: Beyond the 3' end: experimental validation of extended transcript isoforms. Nucleic Acids Res 35: 1947-1957, 2007.
40. Lutz CS: Alternative polyadenylation: a twist on mRNA 3' end formation. ACS Chem Biol 3: 609-617, 2008.
41. Heuze-Vourc'h N, Leblond V and Courty Y: Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen). Eur J Biochem 270: 706-714, 2003.
42. Liu H and Johnson EM: Distinct proteins encoded by alternative transcripts of the PURG gene, located contrapodal to WRN on chromosome 8, determined by differential termination/polyadenylation. Nucleic Acids Res 30: 2417-2426, 2002.
43. Yu M, Sha H, Gao Y, Zeng H, Zhu M and Gao X: Alternative 3' UTR polyadenylation of Bzw1 transcripts display differential translation efficiency and tissue-specific expression. Biochem Biophys Res Commun 345: 479-485, 2006.
44. Hughes TA: Regulation of gene expression by alternative untranslated regions. Trends Genet 22: 119-122, 2006.
45. Stojic J, Stohr H and Weber BH: Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expression. BMC Mol Biol 8: 42, 2007.
46. Hager S, Frame FM, Collins AT, Burns JE and Maitland NJ: An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent manner. Hum Gene Ther 19: 840-850, 2008.
47. Legendre M, Ritchie W, Lopez F and Gautheret D: Differential repression of alternative transcripts: a screen for miRNA targets. PLoS Comput Biol 2: e43, 2006.
48. Tan S, Guo J, Huang Q, et al: Retained introns increase putative microRNA targets within 3' UTRs of human mRNA. FEBS Lett 581: 1081-1086, 2007.
49. Sivakumaran TA, Resendes BL, Robertson NG, Giersch AB and Morton CC: Characterization of an abundant COL9A1 transcript in the cochlea with a novel 3' UTR: expression studies and detection of miRNA target sequence. J Assoc Res Otolaryngol 7: 160-172, 2006.
50. Majoros WH and Ohler U: Spatial preferences of microRNA targets in 3' untranslated regions. BMC Genomics 8: 152, 2007.
51. Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ and Trifan OC: Cyclooxygenase-1 and-2 isoenzymes. Int J Biochem Cell Biol 31: 551-557, 1999.
52. Harper KA and Tyson-Capper AJ: Complexity of COX-2 gene regulation. Biochem Soc Trans 36: 543-545, 2008.
53. Hall-Pogar T, Zhang H, Tian B and Lutz CS: Alternative polyadenylation of cyclooxygenase-2. Nucleic Acids Res 33: 2565-2579, 2005.
54. Sawaoka H, Dixon DA, Oates JA and Boutaud O: Tristetraprolin binds to the 3'-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site. J Biol Chem 278: 13928-13935, 2003.
55. Chakrabarty A, Tranguch S, Daikoku T, Jensen K, Furneaux H and Dey SK: MicroRNA regulation of cyclooxygenase-2 during embryo implantation. Proc Natl Acad Sci USA 104: 15144-15149, 2007.
56. Sandberg R, Neilson JR, Sarma A, Sharp PA and Burge CB: Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 320: 1643-1647, 2008.
57. Zlotorynski E and Agami R: A PASport to cellular proliferation. Cell 134: 208-210, 2008.
58. Ghosh T, Soni K, Scaria V, Halimani M, Bhattacharjee C and Pillai B: MicroRNA-mediated up-regulation of an alternatively polyadenylated variant of the mouse cytoplasmic {beta}-actin gene. Nucleic Acids Res 36: 6318-6332, 2008.
59. Gammell P: MicroRNAs: recently discovered key regulators of proliferation and apoptosis in animal cells: identification of miRNAs regulating growth and survival. Cytotechnology 53: 55-63, 2007.
60. Jovanovic M and Hengartner MO: miRNAs and apoptosis: RNAs to die for. Oncogene 25: 6176-6187, 2006.
61. O'Rourke JR, Swanson MS and Harfe BD: MicroRNAs in mammalian development and tumorigenesis. Birth Defects Res C Embryo Today 78: 172-179, 2006.
62. Bandres E, Agirre X, Ramirez N, Zarate R and Garcia-Foncillas J: MicroRNAs as cancer players: potential clinical and biological effects. DNA Cell Biol 26: 273-282, 2007.
63. Dixon DA: Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des 10: 635-646, 2004.
64. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
65. Kutchera W, Jones DA, Matsunami N, et al: Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci USA 93: 4816-4820, 1996.
66. Ristimaki A, Sivula A, Lundin J, et al: Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62: 632-635, 2002.
67. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H and Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58: 4997-5001, 1998.
68. Yoshimura R, Sano H, Masuda C, et al: Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89: 589-596, 2000.
69. Tucker ON, Dannenberg AJ, Yang EK, et al: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59: 987-990, 1999.
70. Ristimaki A, Nieminen O, Saukkonen K, Hotakainen K, Nordling S and Haglund C: Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am J Pathol 158: 849-853, 2001.
71. Ristimaki A, Honkanen N, Jankala H, Sipponen P and Harkonen M: Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276-1280, 1997.
72. Ratnasinghe D, Tangrea J, Roth MJ, et al: Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res 19: 171-174, 1999.
73. Chan G, Boyle JO, Yang EK, et al: Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59: 991-994, 1999.
74. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
75. Wiestner A, Tehrani M, Chiorazzi M, et al: Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood 109: 4599-4606, 2007.
76. Yu Z, Wang C, Wang M, et al: A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 182: 509-517, 2008.
77. Nosho K, Kawasaki T, Chan AT, et al: Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype. Histopathology 53: 588-598, 2008.
78. Elsheikh S, Green AR, Aleskandarany MA, et al: CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome. Breast Cancer Res Treat 109: 325-335, 2008.
79. Radovic S, Babic M, Doric M, et al: Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors. Bosn J Basic Med Sci 7: 205-211, 2007.
80. Shakir R, Ngo N and Naresh KN: Correlation of cyclin D1 transcript levels, transcript type and protein expression with proliferation and histology among mantle cell lymphoma. J Clin Pathol 61: 920-927, 2008.
81. Chen RW, Bemis LT, Amato CM, et al: Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 112: 822-829, 2008.